Viewing Study NCT01565733


Ignite Creation Date: 2025-12-25 @ 2:53 AM
Ignite Modification Date: 2026-03-01 @ 5:55 PM
Study NCT ID: NCT01565733
Status: COMPLETED
Last Update Posted: 2016-10-31
First Post: 2012-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module